Do big Pharma need to re-address their key

competencies? Professor Luigi

Martini

Patrick Crowley

Steve Wicks

Kurt Hertogs

Alex Robertson

13.35 – 14.35

Current Situation Recent news of Merck shedding a further 8,000 jobs, AZ relocation to Cambridge, Abbott

demerging and Pfizer perhaps demerging into separate business units

–   Is    the  monolithic  big  pharma  organisa2on  which  single  handily  discovers,  develops,  manufactures  and  markets  new  drug  products  under  one  roof  now  gone?  

 

In 2007, a US 'think tank' discussed the Seven Key Skill Sets needed for the Pharmaceutical Industry, as follows: –  Ability  to  manage  decentralised  intellectual  capital  resources  –  Ability  to  work  in  Joint  Ventures  and  across  divisions,  cultures  and  countries  

–  Ability  to  integrate  an  understanding  of  IP  laws,  scien2fic  exper2se  and  strategy  

–  Ability  to  spur  crea2vity  while  managing  commercially  –  Knowledge  and  insight  on  decision  making  dynamics  of  payers  –  Exper2se  in  func2on  and  decision  making  of  regulatory  agencies  –  HR  skills  to  help  transform  pharmaceu2cal  companies